This inventor holds 1 USPTO granted patent. Top assignee: International Technidyne Corporation. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Paul Michael D'Agostino: Innovator in Prothrombin Time Reagents
Introduction
Paul Michael D'Agostino is a notable inventor based in Staten Island, NY (US). He has made significant contributions to the field of medical diagnostics, particularly in the preparation of dried synthetic prothrombin time reagents. His innovative work has implications for blood analysis and patient care.
Latest Patents
D'Agostino holds a patent for the "Preparation of dried synthetic prothrombin time reagents." This patent describes a method for preparing an air-dried prothrombin time (PT) reagent that utilizes a recombinant protein sourced from rabbit brain and synthetic phospholipids, specifically palmitoyloleoylphosphatidylcholine (POPC) and palmitoyloleoylphosphatidylserine (POPS). The formulation buffer used to dilute the lipidated tissue factor allows for a reagent that can be dried without lyophilization, maintaining stability for at least two weeks at 37°C. Additionally, the patent outlines methods for preparing the improved PT reagent and utilizing it for blood PT analysis. D'Agostino has 1 patent to his name.
Career Highlights
D'Agostino is currently employed at International Technidyne Corporation, where he continues to advance his research and development efforts in medical diagnostics. His work is crucial in enhancing the accuracy and reliability of blood testing methods.
Collaborations
D'Agostino collaborates with esteemed colleagues, including Anne Jessica Gorman and Ted C K Lee, who contribute to his innovative projects and research initiatives.
Conclusion
Paul Michael D'Agostino is a prominent figure in the field of medical diagnostics, with a focus on improving prothrombin time reagents. His contributions are vital for advancing blood analysis techniques and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile